Atlas Trials

A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

Clinical trial NCT01801397 · UNKNOWN

Trial details

NCT number
NCT01801397
Sponsor
University of Zurich
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Low Bone Mass in Anorexia Nervosa Patients
Start date
2014-03-01
Primary completion
2016-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.